Longitudinal Assessment of Amyloid-β Deposition by [18F]-Flutemetamol PET Imaging Compared With [11C]-PIB Across the Spectrum of Alzheimer’s Disease

Longitudinal Assessment of Amyloid-β Deposition by [18F]-Flutemetamol PET Imaging Compared With [11C]-PIB Across the Spectrum of Alzheimer’s Disease

This study evaluates the longitudinal changes in the amyloid-β (Aβ) deposition with [18F]-flutemetamol (FMM) PET imaging across the spectrum of Alzheimer’s disease (AD), compared with [11C]-Pittsburgh Compound-B (PIB) PET. Eleven AD, 17 mild cognitive impairment (MCI) and 13 cognitively normal (CN)...

Full description

Bibliographic Details
Main Authors: Shizuo Hatashita, Daichi Wakebe, Yuki Kikuchi, Atsushi Ichijo
Format: Article
Language:English
Published: Frontiers Media S.A. 2019-09-01
Series:Frontiers in Aging Neuroscience
Subjects:
Alzheimer’s disease
amyloid imaging
PET
amyloid beta
flutemetamol
Online Access:https://www.frontiersin.org/article/10.3389/fnagi.2019.00251/full

Internet

https://www.frontiersin.org/article/10.3389/fnagi.2019.00251/full

Similar Items